Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)
PHASE1CompletedINTERVENTIONAL
Enrollment
42
Participants
Timeline
Start Date
January 31, 2013
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
Conditions
Chronic Hepatitis C Infection
Interventions
DRUG
IDX719
50 mg tablet for oral administration
DRUG
Simeprevir
150 mg capsule for oral administration
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT01813513 - Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004) | Biotech Hunter | Biotech Hunter